Amanda Grippen Goddard, D.O.
NPI 1710399654 · Allergy & Immunology Physician · Albuquerque, NM
Enrolled with Medicare as Practitioner - Allergy/Immunology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1710399654
- Entity type
- Individual
- Primary specialty
- Allergy & Immunology PhysicianAllopathic & Osteopathic Physicians
- Credential
- D.O.
- Sex
- Female
- Sole proprietor
- No
- License
- A233920 (NM)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
12 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
8,028 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Test for Allergy Using Allergenic Extract95004 | 3,225 | $3 |
| Professional Service for Preparation and Provision of 1 Or More Antigens95165 | 2,590 | $12 |
| Professional Service for Multiple Injections of Allergen95117 | 1,602 | $11 |
| Professional Service for Single Injection of Allergen95115 | 231 | $9 |
| Administration and Interpretation of Patient-Focused Health Risk Assessment96160 | 81 | $3 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 70 | $13 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 22 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Azelastine Hcl | 120 | 71 |
| Ipratropium Bromide | 76 | 40 |
| Montelukast Sodium | 69 | 22 |
| Hydroxyzine Hcl | 42 | 12 |
| Tiotropium Bromidebrand: Spiriva Respimat | 39 | 11 |
| Fluticasone Propionate | 37 | 21 |
| Budesonide/Formoterol Fumaratebrand: Symbicort | 35 | 12 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,403 across 74 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-05-27
- Last updated
- 2023-10-30
- Certified
- 2023-10-30
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.